Does FIT for CRC screening detect other potential health conditions that can impact the subsequent management decisions?
Authors: Jesús González-Enríquez, Francesca Gillespie, Stefania Lopatriello, Iñaki Imaz
Internal reviewers: Pseudo125 Pseudo125
Refer to domain search and domain methodology section.
We have not identified clinical trials or systematic reviews comparing FIT vs gFOBT in terms of other health effects or clinical conditions not included in the project scope and requiring subsequent clinical management decisions. Therefore no direct evidence on other potential health conditions comparing FIT vs gFOBT in the context of a population based colorectal cancer screening program is available.
González-Enríquez J et al. Result Card EFF14 In: González-Enríquez J et al. Clinical Effectiveness In: Jefferson T, Cerbo M, Vicari N [eds.]. Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali; 2014. [cited 28 June 2022]. Available from: http://corehta.info/ViewCover.aspx?id=206